285 related articles for article (PubMed ID: 11830459)
1. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns.
Streiff MB; Smith B; Spivak JL
Blood; 2002 Feb; 99(4):1144-9. PubMed ID: 11830459
[TBL] [Abstract][Full Text] [Related]
2. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic options for essential thrombocythemia and polycythemia vera.
Solberg LA
Semin Oncol; 2002 Jun; 29(3 Suppl 10):10-5. PubMed ID: 12096352
[TBL] [Abstract][Full Text] [Related]
4. Management of Polycythemia Vera: A Survey of Canadian Physician Practice Patterns.
Habib LA; Kuo KHM; Panzarella T; Gupta V; Trinkaus M
Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):e37-e42. PubMed ID: 30322792
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and treatment of polycythemia vera patients in clinical practice: a multicenter chart review on 1476 individuals in Germany.
Jentsch-Ullrich K; Eberhardt J; Zeremski V; Koehler M; Wolleschak D; Heidel FH
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2041-9. PubMed ID: 27431664
[TBL] [Abstract][Full Text] [Related]
6. Polycythemia Vera.
Spivak JL
Curr Treat Options Oncol; 2018 Mar; 19(2):12. PubMed ID: 29516275
[TBL] [Abstract][Full Text] [Related]
7. Practice Patterns in the Diagnosis and Treatment of Polycythemia Vera in the Post-JAK2 V617F Discovery Era.
Kander EM; Moliterno AR; Rademaker A; Streiff MB; Spivak JL; Stein BL
J Natl Compr Canc Netw; 2016 Oct; 14(10):1238-1245. PubMed ID: 27697978
[TBL] [Abstract][Full Text] [Related]
8. [Chronic progressive polycythemia and thrombocytosis].
Forkert R; Ko Y; Fronhoffs S; Tschubel K; Vetter H
Praxis (Bern 1994); 2001 Apr; 90(17):741-6. PubMed ID: 11387815
[TBL] [Abstract][Full Text] [Related]
9. A mail survey of United States hematologists and oncologists: a comparison of business reply versus stamped return envelopes.
Streiff MB; Dundes L; Spivak JL
J Clin Epidemiol; 2001 Apr; 54(4):430-2. PubMed ID: 11297894
[TBL] [Abstract][Full Text] [Related]
10. How to manage polycythemia vera.
Passamonti F
Leukemia; 2012 May; 26(5):870-4. PubMed ID: 22157736
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.
Michiels JJ; Barbui T; Finazzi G; Fuchtman SM; Kutti J; Rain JD; Silver RT; Tefferi A; Thiele J
Leuk Lymphoma; 2000 Jan; 36(3-4):239-53. PubMed ID: 10674896
[TBL] [Abstract][Full Text] [Related]
12. The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.
Ruggeri M; Tosetto A; Frezzato M; Rodeghiero F
Ann Intern Med; 2003 Sep; 139(6):470-5. PubMed ID: 13679323
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
[TBL] [Abstract][Full Text] [Related]
14. Management of patients with polycythaemia vera: results of a survey among Swedish haematologists.
Andreasson B; Löfvenberg E; Westin J
Eur J Haematol; 2005 Jun; 74(6):489-95. PubMed ID: 15876252
[TBL] [Abstract][Full Text] [Related]
15. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of diagnostic criteria in polycythemia vera.
Pearson TC
Semin Hematol; 2001 Jan; 38(1 Suppl 2):21-4. PubMed ID: 11242598
[TBL] [Abstract][Full Text] [Related]
17. Inapparent polycythemia vera: an unrecognized diagnosis.
Lamy T; Devillers A; Bernard M; Moisan A; Grulois I; Drenou B; Amiot L; Fauchet R; Le Prise PY
Am J Med; 1997 Jan; 102(1):14-20. PubMed ID: 9209196
[TBL] [Abstract][Full Text] [Related]
18. Relevance of early diagnosis in polycythemia vera and essential thrombocythemia: A single center's experience.
Lakhwani S; Pardina-Echevarría M; Arcas-Vega R; Díaz-Sánchez OR; Hernández-García MT; Raya JM
Rev Clin Esp (Barc); 2022 Mar; 222(3):169-173. PubMed ID: 34657827
[TBL] [Abstract][Full Text] [Related]
19. Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera.
Barbui T; Passamonti F; Accorsi P; Pane F; Vannucchi AM; Velati C; Gale RP; Tura S; Barosi G
Leukemia; 2018 Sep; 32(9):2077-2081. PubMed ID: 29955128
[No Abstract] [Full Text] [Related]
20. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2011 Mar; 86(3):292-301. PubMed ID: 21351120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
